Vertex Pharmaceuticals Incorporated Investors: [email protected] Susie Lisa, CFA: +1 617-341-6108 or Miroslava Minkova: +1 617-341-6135 Media: [email protected] or International: +44 20 3204 ...

This week's CPI report is expected to be on the hotter side. While that may come as news to some, the market has been preparing for a breakout in inflation across the swaps curve. Inflation ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

The flood of Chinese imports that started hitting America a quarter-century ago radically altered the U.S. economy. It upended manufacturing communities, hurt workers and their families, and sowed ...

Despite the substantial stock slump earlier this week, Nvidia shares were up 0.6% at 125.41 on Friday. The market could remain volatile into this week as analysts weigh the long-term implications ...

With suzetrigine, developed by pharmaceutical company Vertex, they finally succeeded. The FDA’s approval is based on two phase 3 clinical trials conducted in patients after tummy tuck and bunion ...

People have played it for decades and it’s a popular activity at bars and pubs. However, the digital pool has only been around for a couple of decades or so. The genre has evolved quite a bit ...

This profound discovery paints a picture of a time when the Martian climate was seemingly warm enough to support liquid bodies water, not just frozen ice fields, that were open to the air. “The shape ...

Vertex Pharmaceuticals has scored an FDA approval for Journavx (suzetrigine), a non-opioid pain reliever that could usher in a new era of nonaddictive therapy in the indication. As an oral voltage ...

Might the DeepSeek shock increase Trump’s determination to contain China? For one thing, Trump can’t be happy that China just stole his White House’s AI thunder. It sure seems like a ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...